It’s a New Era

Culture-Independent Tests for Rapid Detection of Sepsis-Causing Pathogens that Lead to Positive Healthcare Outcomes

Wednesday, July 27
10:15 – 11:15 a.m.
Exhibit Hall Theater 3
Supported by T2 Biosystems


Culture-independent tests have shifted the paradigm in species identification for bloodstream infections. Current diagnostic tests for bloodstream infections have limited sensitivity and extended time to identification of sepsis causative pathogens. T2 Biosystems Panels detect sepsis-causing pathogens direct from whole blood. Faster identification of causative pathogens with T2 Biosystems Panels leads to positive clinical and economic outcomes in sepsis patients, including reduced length of hospital stay, improved savings in hospital costs, and improved antimicrobial/antifungal stewardship.


After attending this session, participants will be able to:

  • Explain the technology and role of culture-independent molecular diagnostics in healthcare.
  • Distinguish how culture-independent rapid diagnostics are clinically useful as a tool for better patient care.
  • Apply culture-independent rapid diagnostic technology into current practice standards.


Aparna Ahuja, MD
Chief Medical Officer
Lexington, MA


Thomas J. Walsh, MD, PhD
Center for Innovative Therapeutics and Diagnostics